Status:
UNKNOWN
Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Cervical Cancer
Breast Cancer
Eligibility:
FEMALE
18-50 years
Brief Summary
In this study proposal, the investigators will extend their previous studies and examine the kinetic cytotoxic activity with concordant expression of inhibitory natural killer (NK) receptors (iNKR) on...
Detailed Description
In our extended studies, we have directly examined the expressions of various inhibitory natural killer cell Receptors (iNKRs) on Tumor-infiltrating lymphocytes (TILs) derived from human Cervical canc...
Eligibility Criteria
Inclusion
- Cancer patients
- Healthy volunteers
Exclusion
- Immunosuppression
- HIV carrier
Key Trial Info
Start Date :
July 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00173290
Start Date
July 1 2004
End Date
December 1 2006
Last Update
June 3 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100